Berkonomics
MAY 9, 2024
The dominant player in any niche controls pricing for all those under it, and often sets the risk profile for new entrants into the niche if the dominant player’s products or services fill the needs of customers at reasonable prices and quality. A core patent or “thicket” of patents protecting your offering?
Startup Professionals Musings
MAY 1, 2021
You have figured out how to undercut your competitor’s price, and still hold your margin. Working on that unique design, or completing the breakthrough for an innovative patent, are moments of inspiration that you will never forget, especially if they become your competitive edge. Love that sustainable competitive advantage.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
DECEMBER 14, 2018
Pharmaceutical industry critics lament the cost of rare disease drugs, but some of the steepest price hikes have come on widely used insulin. The patent holder, the University of Toronto, gave companies the right to manufacture insulin. to offer competitive pricing pressure. to offer competitive pricing pressure.
Xconomy
JULY 24, 2020
EQRx launched in January during the JP Morgan Healthcare Conference with an audacious pledge to create 10 new drugs in as many years and then sell them at “dramatically” lower prices than existing medicines. But it offered few specifics about how it would achieve those goals.
Startup Professionals Musings
APRIL 29, 2023
The critical success factors for a product business are well known, starting with selling every unit with a gross margin of 50 percent or more, building a patent and other intellectual property, and continuous product improvement. Indeed, there are some success factors that are common to both environments.
Startup Professionals Musings
AUGUST 3, 2020
The critical success factors for a product business are well known, starting with selling every unit with a gross margin of 50 percent or more, building a patent and other intellectual property, and continuous product improvement. Indeed, there are some success factors that are common to both environments.
Xconomy
SEPTEMBER 6, 2019
Being first to market with a new type of drug brings advantages. The first mover sets the bar for what physicians, payers, and patients can expect of that medicine and how much it costs. It grabs market share that followers have to steal away. But the first mover isn’t infallible if someone else has something better. is counting on.
Expert insights. Personalized for you.
156 
Let's personalize your content